Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis

Yan Huang,Shizhong Han,Yao Li,Yumin Mao,Yi Xie

DOI: https://doi.org/10.1007/s10038-006-0082-5

2006-01-01

Journal of Human Genetics

Abstract:Association studies on the MTHFR polymorphisms (C677T and A1298C) in colorectal cancer (CRC) and colorectal adenoma have shown conflicting results. We performed a meta-analysis to better assess the purported associations. Overall, the 677T allele (10,131 patients and 15,362 controls) showed a small but significant protective effect against CRC compared to the 677C allele [ P =0.0003, odds ratio (OR)=0.93; 95% confidence interval (CI) 0.89–0.98, P =0.22 (for heterogeneity)] for a worldwide population. Meta-analyses of other genetic contrasts suggested that the 677T allele is more likely to affect CRC in a recessive genetic model worldwide ( P <0.0001, OR=0.86; 95% CI 0.76–0.96, P =0.06) and in Asians ( P =0.0005, OR=0.75; 95% CI 0.64–0.88, P =0.71). Similarly, we found a significantly decreased risk of CRC for 1298C polymorphism (4,764 CRC patients and 6,592 controls) for a recessive genetic model worldwide ( P =0.005, OR=0.81; 95% CI 0.70–0.94, P =0.40) and in Caucasians ( P =0.04, OR=0.75 95% CI 0.57–0.99, P =0.35). No evidence of association of C677T (4,616 patients and 6,338 controls) and A1298C (1,272 patients and 1,684 controls) with colorectal adenoma were found. The evidence accumulated suggests that MTHFR may represent a low-penetrance susceptible gene for CRC, and that the two polymorphisms might protect against colorectal adenoma developing into cancer. A larger single study is required to further evaluate gene–gene and gene–environment interactions for MTHFR polymorphisms and the cancer risk in a specific population.